| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.47 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |